These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 22897830

  • 1. Renal transplantation in sensitized recipients with positive luminex and negative CDC (complement-dependent cytotoxicity) crossmatches.
    Huh KH, Kim MS, Kim HJ, Joo DJ, Kim BS, Ju MK, Kim SI, Kim YS.
    Transpl Int; 2012 Nov; 25(11):1131-7. PubMed ID: 22897830
    [Abstract] [Full Text] [Related]

  • 2. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV, Christiaans MH, van den Berg-Loonen EM.
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [Abstract] [Full Text] [Related]

  • 3. The good, the bad, and the ugly of luminex donor-specific crossmatch.
    Chowdhry M, Makroo RN, Thakur Y, Sharma V, Singh M, Kumar M.
    HLA; 2018 Jun; 91(6):501-506. PubMed ID: 29457879
    [Abstract] [Full Text] [Related]

  • 4. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
    Mahmoud KM, Ismail AM, Sheashaa HA, Gheith OA, Kamal MM, Ghoneim MA.
    Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
    Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776
    [Abstract] [Full Text] [Related]

  • 7. Transplantation with positive complement-dependent microcytotoxicity crossmatch in contemporary kidney transplantation: Practice patterns and associated outcomes.
    Graff RJ, Xiao H, Duffy B, Schnitzler MA, Axelrod D, Lentine KL.
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):234-45. PubMed ID: 22382213
    [Abstract] [Full Text] [Related]

  • 8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 9. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 10. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP, Wang CX, Gao W, Fu Q, He XS.
    Exp Clin Transplant; 2010 Jun 27; 8(2):130-5. PubMed ID: 20565369
    [Abstract] [Full Text] [Related]

  • 11. Complement-dependent lymphocytotoxicity crossmatch in deceased donor renal transplant: a single institutional experience.
    Deepa R, Balapriya P, Venkatesh KG, Sabeetha T, Sasikala J, Jayalakshmi G.
    Indian J Med Microbiol; 2011 Jun 27; 29(4):414-7. PubMed ID: 22120805
    [Abstract] [Full Text] [Related]

  • 12. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.
    Abdel Rahman AS, Fahim NM, El Sayed AA, El Hady SA, Ahmad YS.
    Egypt J Immunol; 2005 Jun 27; 12(2):77-89. PubMed ID: 17977213
    [Abstract] [Full Text] [Related]

  • 13. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
    Jin MK, Cho JH, Kwon O, Hong KD, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD.
    Transplant Proc; 2012 Jan 27; 44(1):200-3. PubMed ID: 22310614
    [Abstract] [Full Text] [Related]

  • 14. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y, Yang CW, Moon IS, Kim M, Lim J, Park YJ, Han K, Oh EJ.
    Ann Clin Lab Sci; 2010 Jan 27; 40(4):330-5. PubMed ID: 20947806
    [Abstract] [Full Text] [Related]

  • 15. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
    Akalin E, Ames S, Sehgal V, Fotino M, Daly L, Murphy B, Bromberg JS.
    Transplantation; 2003 Nov 27; 76(10):1444-7. PubMed ID: 14657683
    [Abstract] [Full Text] [Related]

  • 16. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.
    Halloran PF, Schlaut J, Solez K, Srinivasa NS.
    Transplantation; 1992 Mar 27; 53(3):550-5. PubMed ID: 1549846
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P, Canbakan M, Kara M, Özel L, Ünal E, Titiz Mİ.
    Transplant Proc; 2012 Mar 27; 44(6):1652-5. PubMed ID: 22841237
    [Abstract] [Full Text] [Related]

  • 19. T-cell flow-cytometry crossmatch and long-term renal graft survival.
    Rebibou JM, Bittencourt MC, Saint-Hillier Y, Chabod J, Dupont I, Bittard H, Chalopin JM, Hervé P, Tiberghien P.
    Clin Transplant; 2004 Oct 27; 18(5):558-63. PubMed ID: 15344960
    [Abstract] [Full Text] [Related]

  • 20. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar 27; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.